methoxyhydroxyphenylglycol has been researched along with risperidone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, J; Terao, T; Ueda, N; Yoshimura, R | 1 |
| Aymard, N; Caroli, F; Clement, MN; Gauillard, J; Jacquot, M; Vacheron, MN; Viala, A | 1 |
| Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 3 |
| Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Kaneko, S; Nakamura, J; Shinkai, K; Yoshimura, R | 1 |
| Hori, H; Ikenouchi, A; Nakamura, J; Nakano, Y; Ueda, N; Yoshimura, R | 1 |
| Hori, H; Kakihara, S; Mitoma, M; Nakamura, J; Nakano, Y; Ohta, M; Shinkai, K; Shinkai, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R | 1 |
| Hori, H; Korogi, Y; Nakamura, J; Nakano, H; Shimono, M; Shiota, N; Sugita, A; Takano, K; Tomoda, Y; Umene, W; Yoshimura, R | 1 |
| Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Kanno, K; Katsumi, A; Mashiko, H; Miura, I; Niwa, S; Takeuchi, S; Watanabe, K | 1 |
5 trial(s) available for methoxyhydroxyphenylglycol and risperidone
| Article | Year |
|---|---|
Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Serotonin Antagonists; Treatment Outcome | 2000 |
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Schizophrenia; Treatment Outcome | 2003 |
Risperidone in the treatment of psychotic depression.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors | 2006 |
Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Statistics, Nonparametric; Time Factors | 2006 |
Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2012 |
8 other study(ies) available for methoxyhydroxyphenylglycol and risperidone
| Article | Year |
|---|---|
Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanilli
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Risperidone; Schizophrenia; Serotonin; Tryptophan | 2002 |
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking | 2005 |
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2006 |
Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Female; Homovanillic Acid; Humans; Lithium Carbonate; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Risperidone | 2006 |
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Interactions; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2007 |
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Female; Genotype; Humans; Immunoenzyme Techniques; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia | 2007 |
Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's chorea.
Topics: Adolescent; Antipsychotic Agents; Anxiety; Basal Ganglia; Brain-Derived Neurotrophic Factor; Catecholamines; Chorea; Delusions; Electroencephalography; Female; Follow-Up Studies; Hallucinations; Humans; Longitudinal Studies; Methoxyhydroxyphenylglycol; Psychomotor Agitation; Radiography; Risperidone; Tomography, Emission-Computed, Single-Photon | 2009 |
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain-Derived Neurotrophic Factor; Female; Homovanillic Acid; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Young Adult | 2010 |